TCL Archive FDA cancer therapeutics review split among three units in reorganization. October 10, 2003
TCL Archive In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte March 8, 1991
TCL Archive The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year April 20, 2012
TCL Archive Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment June 25, 2004
